FY2025 EPS Estimates for Elutia Lifted by Cantor Fitzgerald

Elutia Inc. (NASDAQ:ELUT - Free Report) - Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Elutia in a note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings of ($0.65) per share for the year, up from their previous forecast of ($0.75). Cantor Fitzgerald currently has a "Overweight" rating and a $8.00 price target on the stock. The consensus estimate for Elutia's current full-year earnings is ($1.74) per share.

Separately, Lake Street Capital cut their price objective on Elutia from $10.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, May 9th.

Elutia Stock Performance

NASDAQ:ELUT opened at $1.90 on Wednesday. The stock has a 50-day simple moving average of $2.49 and a two-hundred day simple moving average of $3.17. Elutia has a 52-week low of $1.71 and a 52-week high of $5.24. The firm has a market capitalization of $77.40 million, a PE ratio of -0.73 and a beta of 0.97.

Elutia (NASDAQ:ELUT - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.01). The firm had revenue of $6.03 million for the quarter, compared to analysts' expectations of $6.65 million.

Hedge Funds Weigh In On Elutia

A number of hedge funds have recently made changes to their positions in ELUT. Perkins Capital Management Inc. lifted its holdings in shares of Elutia by 32.1% in the first quarter. Perkins Capital Management Inc. now owns 1,136,377 shares of the company's stock worth $2,875,000 after buying an additional 276,300 shares in the last quarter. AIGH Capital Management LLC boosted its holdings in shares of Elutia by 10.0% in the 1st quarter. AIGH Capital Management LLC now owns 3,381,415 shares of the company's stock worth $8,555,000 after purchasing an additional 306,740 shares during the period. Arcus Capital Partners LLC bought a new position in Elutia during the first quarter valued at $51,000. Millennium Management LLC lifted its holdings in shares of Elutia by 16.4% in the 4th quarter. Millennium Management LLC now owns 45,217 shares of the company's stock worth $169,000 after acquiring an additional 6,386 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new position in shares of Elutia during the fourth quarter valued at approximately $84,000. Institutional investors own 74.03% of the company's stock.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.